HIMS:NYE-Hims Hers Health Inc (USD)

COMMON STOCK | Household & Personal Products |

Last Closing

USD 15.47

Change

-0.27 (-1.72)%

Market Cap

USD 3.06B

Volume

4.31M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-28 )

Largest Industry Peers for Household & Personal Products

Symbol Name Price(Change) Market Cap
PG Procter & Gamble Company

N/A

USD 373.23B
UL Unilever PLC ADR

N/A

USD 119.76B
CL Colgate-Palmolive Company

N/A

USD 73.02B
EL Estee Lauder Companies Inc

N/A

USD 51.77B
KMB Kimberly-Clark Corporation

N/A

USD 41.74B
CHD Church & Dwight Company Inc

N/A

USD 24.65B
CLX The Clorox Company

N/A

USD 18.11B
COTY Coty Inc

N/A

USD 9.98B
ELF ELF Beauty Inc

N/A

USD 8.70B
NTCO Natura & Co Holding SA

N/A

USD 4.63B

ETFs Containing HIMS

EDOC:LSE Global X Telemedicine & D.. 4.42 % 0.00 %

N/A

USD 5.32M
EDOG:LSE Global X Telemedicine & D.. 4.42 % 0.00 %

N/A

USD 5.32M
IBUY Amplify Online Retail ETF 3.66 % 0.65 %

N/A

USD 0.17B
WELP:LSE HAN-GINS Indxx Healthcare.. 1.81 % 0.00 %

N/A

USD 0.02B
WELL:PA HAN-GINS Indxx Healthcare.. 1.51 % 0.00 %

N/A

N/A
WELL:SW HAN-GINS Indxx Healthcare.. 1.51 % 0.00 %

N/A

N/A
WELL:LSE Hanetf Icav - Han-Gins He.. 0.00 % 0.00 %

N/A

USD 0.02B
W311:XETRA HAN-GINS Indxx Healthcare.. 0.00 % 0.00 %

N/A

USD 0.02B
W311:F HAN-GINS Indxx Healthcare.. 0.00 % 0.00 %

N/A

USD 0.02B

Market Performance

  Market Performance vs. Industry/Classification (Household & Personal Products) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 73.82% 100% F 99% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 73.82% 94% A 99% N/A
Trailing 12 Months  
Capital Gain 56.10% 89% A- 92% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 56.10% 83% B 91% A-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 10.22% 79% B- 73% C
Dividend Return 10.22% 79% B- 68% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 55.52% 16% F 16% F
Risk Adjusted Return 18.41% 53% F 43% F
Market Capitalization 3.06B 44% F 68% D+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.